Management
-
Pieter van der Poel - MBA
Founder & CEO
I have extensive experience in oncology, focusing on breast and lung cancer. As a marketeer, I recognize the crucial role of robust AI tools in screening for lung cancer and other thoracic diseases.
I am committed to advancing these tools, even though such solutions don’t yet exist. Providing people with the knowledge about their lung health is essential. Early screening saves lives, and automation tools will significantly benefit humanity globally.
Screening should be accessible to everyone!
-
Manuela van der Poel - Dipl. Ing.
Chief Marketing & Operations Officer
I am totally determined about driving forward PRMSE: which aims at catching lung cancer early and thus eventually saving lives. We strive for making our tool accessible as soon as possible to each and everyone, providing the chance for a cure.
I am bringing in all the experience from my former positions and the absolute dedication to this important project.
-
Dr. Alex(andru) Puiu - PhD
Chief Scientific Officer
I’m a scientist with extensive R&D experience in AI-driven MedTech and Diagnostics, focused on advancing healthcare and improving patient outcomes. I’ve led global clinical programs, navigated complex regulations, and successfully brought innovative medical technologies to market.
I focus on validating PRMSE:’s disruptive AI tools for early lung cancer detection - a mission inspired by losing my grandfather to late-stage cancer.
Our Vision
PRMSE: Screening for All
PRMSE: uses AI-powered computer vision to interpret low-dose CT lung images for individuals at high risk of lung cancer. Our goal is to make lung cancer screening and early treatment widely accessible, supporting screening programs through partnerships with radiology companies, AI providers, and healthcare organizations.
We are committed to making screening accessible to everyone, starting with those at high risk.
Our Mission
uses AI algorithms to automate the interpretation of low-dose CT lung images, extracting vital information. This creates a reliable screening tool to address the worldwide shortage of radiologists.
By enabling large-scale early-stage lung cancer screening for high-risk individuals, PRMSE: aims to improve access to early detection and treatment.
We work as a key part of lung cancer screening programs through partnerships with radiology companies, AI platform providers, and healthcare organizations.
Our Philosophy
Lung cancer kills more men and women than colon cancer, prostate cancer and breast cancer combined.
If detected early people can get a cure.
PRMSE: aims to give everyone the chance to get screened at an early stage by creating tools that provide robust reading of CT images in an automated way, thus not calling on radiologists. We aim to realise these goals by bringing the experts from all sectors together - clinics, science, AI, healthcare.
Our Values
Respect for the individual
We believe that everyone deserves to know about a severe disease in an early stage where cure still is highly likely.
With PRMSE: as an integral part of a broad, uncomplicated screening program that is accessible to everyone patients safety does not remain an empty promise. The option for early lung cancer detection and subsequently a cure should be available for everyone on the globe.
Passion
We believe that we are able to create the technology that makes early lung cancer screening accessible for everyone.
We are decided to drive this approach and thus contribute to making lung cancer a profoundly curable disease.
Transparency
We bring all relevant experts together to create our product based on their individual knowledge. All stakeholders will always be on the same page.
We communicate our intentions and ideas with clarity and commitment.
Humbleness
We understand that everywhere on the globe experts are doing the utmost to combat lung cancer and are open to the entire expertise coming from them.
We cherish their dedication and effort for the sake of the patients.
Responsibility
We totally understand that our mission comes with a high responsibility to create solutions that can decide over live and death of the individual. We will do anything to ensure the safety of the patient throughout whatever we do. Patients safety has number one priority for us and we will ensure that it is secured at any time. Radiologists are co-developing our product and accompany the development until full reliability is given.
Reliability
We stand to our commitments.
Societal Responsibility
We will contribute to a lung cancer screening project in Afrika, in order to help identify people at risk and to improve their chances of healing.
In addition, we will support a program aimed at preventing young people from picking up smoking.
Our Partners
Testimonials
-
"Throughout my entire academic career I have been advocating public health to be the underpinning of a strong society. Having supported numerous charity projects in the world, I am providing my full support to the societal projects that PRMSE: Screening for All is driving. Only with early screening is the fight against cancer a fair one.”
Dr. Noel M. Tichy is a Professor of Management & Organizations at the Ross School of Business at the University of Michigan
-
“Estimation of risk in lung cancer screening I see as an important. Ever improving this estimation based on images and other information serves the population at risk for lung cancer. The path PRMSE: is on holds promise."
Prof. Sveta Zinger, Associate Professor , Eindhoven University of Technology, Department of Electrical Engineering
